Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 2
2006 2
2007 1
2008 3
2009 3
2010 10
2011 11
2012 12
2013 6
2014 5
2015 12
2016 17
2017 15
2018 8
2019 11
2020 4
2021 7
2022 8
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

133 results

Results by year

Filters applied: . Clear all
Page 1
A highly virulent variant of HIV-1 circulating in the Netherlands.
Wymant C, Bezemer D, Blanquart F, Ferretti L, Gall A, Hall M, Golubchik T, Bakker M, Ong SH, Zhao L, Bonsall D, de Cesare M, MacIntyre-Cockett G, Abeler-Dörner L, Albert J, Bannert N, Fellay J, Grabowski MK, Gunsenheimer-Bartmeyer B, Günthard HF, Kivelä P, Kouyos RD, Laeyendecker O, Meyer L, Porter K, Ristola M, van Sighem A, Berkhout B, Kellam P, Cornelissen M, Reiss P, Fraser C; Netherlands ATHENA HIV Observational Cohort†; BEEHIVE Collaboration†. Wymant C, et al. Among authors: van sighem a. Science. 2022 Feb 4;375(6580):540-545. doi: 10.1126/science.abk1688. Epub 2022 Feb 3. Science. 2022. PMID: 35113714 Free article.
Is reaching 90-90-90 enough to end AIDS? Lessons from Amsterdam.
de Bree GJ, van Sighem A, Zuilhof W, van Bergen JEAM, Prins M, Heidenrijk M, van der Valk M, Brokx P, Reiss P; HIV Transmission Elimination AMsterdam (H-TEAM) Initiative. de Bree GJ, et al. Among authors: van sighem a. Curr Opin HIV AIDS. 2019 Nov;14(6):455-463. doi: 10.1097/COH.0000000000000586. Curr Opin HIV AIDS. 2019. PMID: 31589173 Review.
HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysis.
Loosli T, Hossmann S, Ingle SM, Okhai H, Kusejko K, Mouton J, Bellecave P, van Sighem A, Stecher M, d'Arminio Monforte A, Gill MJ, Sabin CA, Maartens G, Günthard HF, Sterne JAC, Lessells R, Egger M, Kouyos RD. Loosli T, et al. Among authors: van sighem a. Lancet HIV. 2023 Nov;10(11):e733-e741. doi: 10.1016/S2352-3018(23)00228-X. Epub 2023 Oct 10. Lancet HIV. 2023. PMID: 37832567
Discriminating Between Premigration and Postmigration HIV Acquisition Using Surveillance Data.
Pantazis N, Rosinska M, van Sighem A, Quinten C, Noori T, Burns F, Cortes Martins H, Kirwan PD, O'Donnell K, Paraskevis D, Sommen C, Zenner D, Pharris A. Pantazis N, et al. Among authors: van sighem a. J Acquir Immune Defic Syndr. 2021 Oct 1;88(2):117-124. doi: 10.1097/QAI.0000000000002745. J Acquir Immune Defic Syndr. 2021. PMID: 34138772
Cost-effectiveness of increased HIV testing among MSM in The Netherlands.
Reitsema M, Steffers L, Visser M, Heijne J, van Hoek AJ, Schim van der Loeff M, van Sighem A, van Benthem B, Wallinga J, Xiridou M, Mangen MJ. Reitsema M, et al. Among authors: van sighem a. AIDS. 2019 Oct 1;33(12):1807-1817. doi: 10.1097/QAD.0000000000002199. AIDS. 2019. PMID: 30889012
Phylogenetic estimation of the viral fitness landscape of HIV-1 set-point viral load.
Zhao L, Wymant C, Blanquart F, Golubchik T, Gall A, Bakker M, Bezemer D, Hall M, Ong SH, Albert J, Bannert N, Fellay J, Grabowski MK, Gunsenheimer-Bartmeyer B, Günthard HF, Kivelä P, Kouyos RD, Laeyendecker O, Meyer L, Porter K, van Sighem A, van der Valk M, Berkhout B, Kellam P, Cornelissen M, Reiss P, Fraser C, Ferretti L. Zhao L, et al. Among authors: van sighem a. Virus Evol. 2022 Mar 16;8(1):veac022. doi: 10.1093/ve/veac022. eCollection 2022. Virus Evol. 2022. PMID: 35402002 Free PMC article.
Integrase strand-transfer inhibitor use and cardiovascular events in adults with HIV: an emulation of target trials in the HIV-CAUSAL Collaboration and the Antiretroviral Therapy Cohort Collaboration.
Rein SM, Lodi S, Logan RW, Touloumi G, Antoniadou A, Wittkop L, Bonnet F, van Sighem A, van der Valk M, Reiss P, Klein MB, Young J, Jarrin I, d'Arminio Monforte A, Tavelli A, Meyer L, Tran L, Gill MJ, Lang R, Surial B, Haas AD, Justice AC, Rentsch CT, Phillips A, Sabin CA, Miro JM, Trickey A, Ingle SM, Sterne JAC, Hernán MA; Antiretroviral Therapy Cohort Collaboration and the HIV-CAUSAL Collaboration. Rein SM, et al. Among authors: van sighem a. Lancet HIV. 2023 Nov;10(11):e723-e732. doi: 10.1016/S2352-3018(23)00233-3. Lancet HIV. 2023. PMID: 37923486
sHIV-1 drug resistance in people on dolutegravir-based ART: Collaborative analysis of cohort studies.
Loosli T, Hossmann S, Ingle SM, Okhai H, Kusejko K, Mouton J, Bellecave P, van Sighem A, Stecher M, d'Arminio Monforte A, Gill MJ, Sabin CA, Maartens G, Günthard HF, Sterne JAC, Lessells R, Egger M, Kouyos R. Loosli T, et al. Among authors: van sighem a. medRxiv [Preprint]. 2023 Apr 5:2023.04.05.23288183. doi: 10.1101/2023.04.05.23288183. medRxiv. 2023. PMID: 37066200 Free PMC article. Updated. Preprint.
Many but small HIV-1 non-B transmission chains in the Netherlands.
Bezemer D, Blenkinsop A, Hall M, van Sighem A, Cornelissen M, Wessels E, van Kampen J, van de Laar T, Reiss P, Fraser C, Ratmann O. Bezemer D, et al. Among authors: van sighem a. AIDS. 2022 Jan 1;36(1):83-94. doi: 10.1097/QAD.0000000000003074. AIDS. 2022. PMID: 34618753 Free PMC article.
133 results